Evidence map›Paper›PMID 25512646›Full record

Observational studyClinical journal of the American Society of Nephrology : CJASN2015

Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD.

Yi-Chun Tsai, Yi-Wen Chiu, Jer-Chia Tsai, Hung-Tien Kuo, Chi-Chih Hung, Shang-Jyh Hwang, Tzu-Hui Chen, Mei-Chuan Kuo, Hung-Chun Chen

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Ten tips for the first hemodialysis sessions.Clinical kidney journal · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yi-Chun TsaiGraduate Institute of Clinical Medicine and Division of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan;
Yi-Wen ChiuDivision of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan;
Jer-Chia TsaiDivision of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan;
Hung-Tien KuoDivision of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan;
Chi-Chih HungDivision of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan;
Shang-Jyh HwangGraduate Institute of Clinical Medicine and Division of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan; Institute of Population Sciences, National Health Research Institutes, Miaoli, Taiwan.
Tzu-Hui ChenDepartment of Nursing, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; and.
Mei-Chuan KuoGraduate Institute of Clinical Medicine and Division of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan; mechku@cc.kmu.edu.tw.
Hung-Chun ChenDivision of Nephrology and Faculty of Renal Care, Kaohsiung Medical University, Kaohsiung, Taiwan;
Pediatric Nephrology of Alabama · USKaohsiung Medical University · TWInstitute of Clinical Research · USNational Health Research Institutes · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesFluid overload is a common characteristic associated with renal progression in CKD. Additionally, fluid overload is an independent predictor of all-cause or cardiovascular mortality in patients on dialysis, but its influence on patients not on dialysis is uncertain. The aim of the study was to assess the relationship between the severity of fluid status and clinical outcomes in an advanced CKD cohort. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 478 predialysis patients with stages 4 and 5 CKD in the integrated CKD care program were enrolled from January of 2011 to December of 2011 and followed-up until August of 2013. The clinical outcomes included cardiovascular morbidity and all-cause mortality. The relative hydration status (overhydration/extracellular water) was used as the presentation of the severity of fluid status and measured using a body composition monitor. Overhydration/extracellular water >7% was defined as fluid overload.

resultsOver a median follow-up period of 23.2 (12.6-26.4) months, 66 (13.8%) patients reached all-cause mortality or cardiovascular morbidity. The adjusted hazard ratio of the combined outcome of all-cause mortality or cardiovascular morbidity for every 1% higher overhydration/extracellular water was 1.08 (95% confidence interval, 1.04 to 1.12; P<0.001). The adjusted overhydration/extracellular water for the combined outcome of all-cause mortality or cardiovascular morbidity in participants with overhydration/extracellular water ≥7% compared with those with overhydration/extracellular water <7% was 1.93 (95% confidence interval, 1.01 to 3.69; P=0.04). In subgroup analysis, higher overhydration/extracellular water was consistently associated with increased risk for the combined outcome independent of diabetes, cardiovascular disease, and serum albumin. There was no significant interaction between all subgroups.

conclusionsThese findings suggest that fluid overload is an independent risk factor of the combined outcome of all-cause mortality or cardiovascular morbidity in patients with advanced CKD.

Indexed as

AgedBody CompositionCardiovascular DiseasesCause of DeathDisease ProgressionFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisRenal Insufficiency, ChronicRisk AssessmentRisk FactorsSeverity of Illness IndexTaiwancardiovascular diseaseCKDmortality

Identifiers

PMID25512646
PMCPMC4284411
OpenAlexW2171427920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.